Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sweet News For McNeil: Splenda Health Claim Approved By FDA

This article was originally published in The Tan Sheet

Executive Summary

FDA is proposing to amend the regulation allowing a health claim on non-cavity-causing sweeteners to allow sucralose, an ingredient included in McNeil Nutritionals' Splenda No-Calorie Sweetener

You may also be interested in...



Omega-3 claims

"Immediate action" to allow nutrient claims for fatty acids "will have significance far beyond the realm of heart disease prevention," the American Institute for Cancer Research maintains in comments to FDA. Claims could encourage consumers to select foods with protective effects, rather than "over-consuming omega-6 fatty acids," which are thought to induce cancer if consumed in excess, AICR says. Separately, Shape Up America! suggests "this action alone could be an important step in reducing the risk for cardiovascular disease, one of the leading co-morbid conditions for obesity"...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS098207

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel